| Contribution to headline earnings | 30 June 2023 R million |
30 June 2022 R million |
|---|---|---|
| Central treasury | ||
| – Finance income | 650 | 224 |
| – Finance costs | (628) | (627) |
| Net corporate income/(costs) | 205 | (252) |
| 227 | (655) | |
Responsible for Remgro’s central treasury function as well as management and support services.
Finance income amounted to R650 million (2022: R224 million). This increase is mainly due to the increase in the South African repo rate and a higher average cash balance, due to the disposal of 60 million FirstRand shares and Remgro’s investment in Grindrod Shipping. Finance costs amounted to R628 million (2022: R627 million). Other net corporate income of R205 million (2022: net corporate costs of R252 million) includes an after-tax foreign exchange gain of R522 million realised on foreign exchange contracts entered in respect of the acquisition of the additional 5.4% indirect interest in Mediclinic.